Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Radiation-Induced Lung Injury via miRNA-214-3p

Xudan Lei,Ningning He,Lihong Zhu,Manqian Zhou,Kaiyue Zhang,Chen Wang,Haoyan Huang,Shang Chen,Yuhao Li,Qiang Liu,Zhibo Han,Zhikun Guo,Zhongchao Han,Zongjin Li
DOI: https://doi.org/10.1089/ars.2019.7965
2021-10-10
Antioxidants and Redox Signaling
Abstract:Aims: Radiotherapy is an effective treatment for thoracic malignancies, but it can cause pulmonary injury and may lead to respiratory failure in a subset of patients. Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) are now recognized as a new candidate for cell-free treatment of lung diseases. Here, we investigated whether MSC-derived EVs (MSC-EVs) could ameliorate radiation-induced lung injury. Results: We exposed mice to thoracic radiation with a total dose of 15 Gy and assessed the protective effects of MSC-EVs on endothelial cells damage, vascular permeability, inflammation and fibrosis. We found that MSC-EVs attenuated radiation-induced lung vascular damage, inflammation, and fibrosis. Moreover, MSC-EVs reduced the levels of radiation-induced DNA damage by downregulating ATM/P53/P21 signaling. Our results confirmed that the downregulation of ATM was regulated by miR-214-3p, which was enriched in MSC-EVs. Further analysis demonstrated that MSC-EVs inhibited the senescence associated secretory phenotype development and attenuated the radiation-induced injury of endothelial cells. Innovation and conclusion: Our study reveals that MSC-EVs can reduce pulmonary radiation injury through transferring miR-214-3p, providing new avenues to minimize lung injury from radiation therapy.
biochemistry & molecular biology,endocrinology & metabolism
What problem does this paper attempt to address?